Motor cortex stimulation for chronic non-malignant pain: current state and future prospects.

Area of Science:

• Neuroscience
• Neurosurgery
• Pain Management

Background:

• Motor cortex stimulation (MCS) was initially developed for post-stroke thalamic pain.
• Indications have expanded to include trigeminal neuropathic pain and other deafferentation pain types.
• Literature reports high success rates (80% facial, 53% non-facial pain), but personal results are less impressive (28% pain relief).

Purpose of the Study:

• To evaluate the effectiveness and identify predictive factors for motor cortex stimulation in treating various types of deafferentation pain.
• To explore the potential role of repetitive transcranial magnetic stimulation (rTMS) as a predictive factor.
• To investigate the mechanisms underlying MCS, including its effects on sensory input rebalancing and emotional perception of pain.

Main Methods:

• Review of existing literature on MCS for deafferentation pain.
• Analysis of personal patient data (14 patients) with MCS for pain relief.
• Consideration of predictive factors such as pharmacological tests, corticospinal tract sparing, and rTMS response.

Main Results:

• Personal study showed 28% of patients experienced >40% pain relief, with temporary effects in some.
• Minor complications were reported.
• Accurate electrode placement and somatotopic correspondence are crucial for efficacy.

Conclusions:

• MCS shows promise for deafferentation pain, but results can be variable.
• Predictive factors like rTMS response and precise electrode placement warrant further investigation.
• A large, multicenter, randomized, double-blind study is recommended to optimize MCS techniques and assess outcomes comprehensively.